2011 ASH Program Book - American Society of Hypertension

Sunday Afternoon MAY 22
Sessions
3:30 PM – 5:15 PM • West Ballroom • Third Floor
3 Comprehensive Multi-Level Interventions for
Hypertension Management in High-Risk Groups
Co-Chairs: Daniel Levy, MD, Framingham, MA and
Robert A. Phillips, MD, PhD, FASH, Worcester, MA
3:30 PM Hypertension in Minorities: A New York State
Clinical Guidance Statement
Joseph L. Izzo, Jr., MD, FASH, Buffalo, NY
3:50 PM Clinical Trial Interventions: Where Have We Gone
Right or Wrong
Bryan Williams, MD, Leicester, United Kingdom
4:10 PM Integrated and Alternate Approaches to Treatment
William J. Elliott, MD, PhD, FASH, Yakima, WA
Original Communications
4:30 PM OR-12: Influence of Inflammatory and
Prothrombotic Factors in Left Ventricular Structure
and Function in Essential Hypertensive Patients
Gregory Vyssoulis, 1 Eva Karpanou, 2 Stella Maria
Kyvelou, 1 I. Barbetseas, 1 C. Stefanadis. 1 1 1st Cardiology
Clinic Athens University Hippokration Hospital, GR;
2 1st Cardiology Clinic Onassis Cardiosurgery Center,
GR.
4:45 PM OR-13: The Kaiser Permanente Northern California
Hypertension Project 2001-2009: How an Integrated
Care Delivery System Increased Blood Pressure
Control Rates from 44% to 80% in 8 Years
Marc G. Jaffe, Joseph D. Young. The Permanente
Medical Group, Oakland, CA, US.
5:00 PM OR-14: Intensive Blood Pressure Control Does Not
Increase Falls and Fractures in Patients with Type 2
Diabetes:The ACCORD Trial
Karen Margolis, 1 Lisa Palermo, 2 Eric Vittinghoff, 2 Hal
Atkinson, 3 Gregory Evans, 3 Bruce Hamilton, 4 Robert
Josse, 5 Patrick O’Connor, 1 Debra Simmons, 6 Margaret
Tiktin, 7 Ann Schwartz. 2 1 HealthPartners Research
Foundation, US; 2 U of CA-SF, US; 3 Wake Forest SOM,
US; 4 Baltimore VAMC, US; 5 University of Toronto,
CA; 6 Central Arkansas Veterans Healthcare System,
US; 7 Case Western Research University, US.
1 Pathobiology Track 2 Translational Track 3 Therapy Track
61